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ABSTRACT
Dershem, Victoria Lynne. M.S., Department of Biochemistry and Molecular Biology, 
Wright State University, 2016. The Expression of Dopamine-Related Genes and 
Behavioral Performance in Mice.
While the neurotransmitter dopamine has been well-studied for its role in mood 
regulation and activation of the intrinsic reward pathway, several psychiatric disorders 
linked to dopamine are also known to cause memory impairment, a phenomenon which 
has attracted much less attention. In the current study, whole-transcriptome RNA 
sequencing was performed, and transcript levels of several dopamine-related genes were 
compared to results of behavioral assays designed to test spatial and emotional memory, 
as well as anxiety. The results suggest a positive relationship between expression level of 
Nurr1, a nuclear receptor known to initiate transcription of genes necessary for 
dopaminergic signaling, and both emotional and spatial memory. However, no correlation
was observed between expression of tyrosine hydroxylase, dopamine transporter, or any 
variant of dopamine receptor, and any of the behavioral results. These results are 
consistent with previous research findings that Nurr1 plays a role in memory 
consolidation, and suggests a dopamine-independent regulation.
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I. INTRODUCTION
Purpose
According to the National Institute of Mental Health, 18.1% of adults and 46.3% 
of children suffered from a mental illness in 2014. In the same year, over 42,000 lives 
were lost to suicide in the United States alone, making it the country's tenth leading cause
of death (Kochanek, Murphy, Xu, & Tejada-Vera., 2016). Furthermore, despite countless 
advances in psychiatric research in recent years, the suicide rate has climbed from 10.5 to
13 per 100,000 individuals since 1999 (Curtin, Warner, & Hedegaard, 2016). It has been 
demonstrated that chronic stress can contribute to development of psychiatric disorders, 
although we are far from fully understanding the biochemical mechanisms by which this 
occurs. Many psychiatric disorders are believed to involve dysregulation of dopamine 
signaling, and therefore, there is tremendous interest in the biochemical causes of these 
disorders. This is a broad field, however, as dopamine signaling is regulated by a diverse 
range of proteins. These include enzymes involved in catecholamine synthesis, 
transporters involved in regulation of synaptic neurotransmitter concentrations, and 
receptors which intercept synaptic dopamine and translate the messenger signal into 
intracellular cascades which lead to transcription, translation, or post-translational 
modification which modulate activity of fully-formed proteins.
Many conditions listed in the Diagnostic and Statistical Manual of  Mental 
Disorders, 5th Edition that are associated with dopamine, such as Major Depressive
1
 Disorder and schizophrenia, feature symptoms relating to impaired or altered ability to 
consolidate or access long-term memory (American Psychiatric Association, 2013). 
While dopamine has been highly studied in regards to mood disturbances, less 
emphasis has been placed on the mechanisms by which the pathophysiology of these 
disorders affects memory formation and/or retrieval. Because of this, the current study 
focuses on dopaminergic signaling in the hippocampus, a neural structure which is 
closely associated with declarative—including emotional and spatial—memory 
(Duvernoy, 2005). By expanding our knowledge of the causes behind memory-related 
psychiatric symptoms, the current study may assist in furthering our knowledge of how to
treat them. 
For this study, critical genes from various aspects of dopaminergic regulation 
(Fig. 1) were examined: tyrosine hydroxylase (TH, Th), which converts tyrosine into L-
DOPA, the precursor to dopamine; the dopamine transporter (DAT, Dat1), which 
facilitates reuptake of unbound synaptic dopamine; the five subtypes of dopamine 
receptor (both excitatory and inhibitory); and NURR1 (Nurr1), a nuclear receptor which 
transcriptionally activates both TH and Dat1. Using RNA sequencing and behavioral 
assays, the current study sought to determine whether or not mRNA expression levels of 
these genes in the hippocampus relate to various measures of memory and emotion after 
exposure to a chronic stress environment. By studying the relationship between 
dopamine-signaling related gene expression and behaviors related to memory and fear, 
insight may be gained into the genetic pathologies of diseases that affect these cognitive 
functions. By narrowing down which genes are most crucial in these pathways, they can 
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then be further investigated in pharmaceutical and other clinical studies.
Dopamine
Dopamine (3,4-Dihydroxyphenethylamine) is an organic biochemical messenger 
that was first synthesized in vitro by George Barger and James Ewens in 1910 (Fahn, 
2008). Arvin Carlsson (who would eventually win the 2000 Nobel Prize in Medicine or 
Physiology for his discoveries) determined that not only is dopamine a precursor to other 
catecholamines, but is a neurotransmitter in its own right (Fahn, 2008). It has since been
discovered that dopamine plays a role in many aspects of neural activity, including 
intrinsic reward, decision making, behavior, and physical movement (Schultz, 2007). 
Upon release of dopamine into the synapse, it accomplishes these functions by binding 
dedicated receptors on the post-synaptic neuron. There are two distinct classes of 
dopamine receptor, both of which are G protein-coupled receptors: the D1-like and the 
D2-like. The D1-like group consists of DRD1 and DRD5, which activate adenyl cyclase 
by coupling to the Gαs protein, while the D2-like group, comprised of DRD2, DRD3, and 
DRD4, inhibit adenyl cyclase by way of the Gαi or Gαo proteins (Beaulieu & 
Gainetdinov, 2011). According to Rondou, Haegeman, and Van Craenenbroeck (2010), 
the affinities of the dopamine receptors, as measured by Ki values, are approximately 
2500 nM for DRD1, 500 nM for DRD2, 20-100 nM for DRD3, 43-400 nM for DRD4 
(depending on allelic variations), and 225 nM for DRD5. Together, these receptors 
modulate the conversion of the neurotransmitter signal into intracellular signaling 
cascades, which can either facilitate or inhibit the phosphorylation of CREB and resulting
gene transcription (Fig. 2).
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Figure 1: Roles of genes examined in the present study. NURR1, a nuclear receptor, is a transcriptional 
activator of dopamine-related genes, such as Th and Dat1. TH converts tyrosine to L-DOPA as part of the 
catecholamine synthesis pathway. DAT regulates synaptic dopamine concentration by facilitating reuptake 
of DA into the presynaptic neuron. Finally, the five subtypes of dopamine receptor (DRD1-5) are found in 
the membrane of the postsynaptic neuron and bind DA that has been released into the synapse.
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The first aspect of the current study was to explore how subjects' mRNA levels of 
the studied genes (including dopamine receptors) varied across the population, despite 
identical handling and stress protocols. At least two studies have demonstrated a decrease
in extraneuronal dopamine levels in response to stress (Ahmad, Rasheed, Banu, & Palit, 
2010; Rasheed et al., 2010), and there is evidence to suggest that dopamine receptor 
expression is inversely proportional to synaptic dopamine concentrations. With this in 
mind, it is important to understand the processes involved in the catecholaminergic 
synthesis pathway and release of DA into the synapse.
The precursor to all catecholamines is the amino acid tyrosine, which goesthrough
a number of enzymatic alterations to reach its final state(s). Tyrosine is first converted to 
L-DOPA by TH, and then to dopamine by L-aromatic amino acid decarboxylase 
(AADC). Alternately, a second, minor pathway exists in which tyrosine undergoes 
decarboxylation and is converted into tyramine (another amino acid) before being 
hydroxylated to dopamine by CYP2D6 (Meiser, Weindl, & Hiller, 2013; Hiroi, Imaoka, 
& Funae, 1998). In dopaminergic neurons, this step is the endpoint. However, in 
(nor)adrenergic neurons, further steps are necessary. Dopamine is converted to 
norepinephrine by dopamine-β-hydroxylase (DBH; Ciaranello, Wooten, & Axelrod, 
1976), and then, as appropriate, to epinephrine by phenylethanolamine N-
methyltransferase (PNMT) (Sabban & Kvetňanský, 2001). These pathways are illustrated
in Fig. 3.
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Figure 2: Dopamine receptors act on adenyl cyclase to stimulate or inhibit CREB-mediated gene 
transcription. The D1-like receptors (DRD1, DRD5) stimulate adenyl cyclase and downstream cascades 
which lead to phosphorylation of CREB and resulting gene transcription. Conversely, the D2-like receptors 
(DRD2, DRD3, DRD4) inhibit adenyl cyclase and prevent these downstream effects. DRS, stimulatory 
dopamine receptors; DRI, inhibitory dopamine receptors; Gαs: stimulatory G-protein alpha subunit; Gαi: 
inhibitory G-protein alpha subunit; cAMP: cyclic adenosine monophosphate; PKA: protein kinase A; 
EPAC: exchange protein activated by cAMP; DARPP-32: dopamine- and cAMP-regulated neuronal 
phosphoprotein; RAP1: Ras-related protein 1; B-Raf, serine/threonine-protein kinase B-Raf; PP1: protein 
phosphatase 1; MEKs: Mitogen-activated protein kinases; ERK: extracellular-signal-regulated kinase; 
CREB: cAMP response element binding protein; pCREB: phosphorylated CREB. Arrows denote 
activation, dotted lines denote inhibition.
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There is some disagreement in the existing literature as to how catecholaminergic 
tyrosine hydroxylase expression is affected by chronic stress. However, in a review of 
existing literature, Sabban and Kvetňanský (2001) concluded that Th mRNA and 
immunoreactivity levels are increased in the ventral tegmental area (a region containing a
relatively high concentration of dopaminergic neurons) as a result of chronic stress, and 
this is consistent with what is known of stress-related activation of the hypothalamic-
pituitary-adrenal (HPA) axis. HPA activation leads to increased production of 
glucocorticoids, and in binding to their receptors, they increase phosphorylation and 
activation of the cAMP response element binding protein (CREB), a transcription factor 
for which a response element is found alongside the NGFI-B response element (NBRE) 
in the promoter region of Th (Ghee, Baker, Miller, & Ziff, 1998). Therefore, while TH is 
regulated at the transcriptional level by NURR1, it has also been demonstrated that Th 
transcription is also inhibited by the downstream effects of increased catecholamine 
concentration (Meiser, Weindl, & Hiller, 2013). Consequently, dopamine itself also 
contributes to negative feedback of catecholamine synthesis through decreasing CREB-
mediated synthesis of TH.
AADC, on the other hand, is regulated primarily by DA receptor-mediated 
phosphorylation. Treatment with dopaminergic antagonists such as SCH23390 or 
haloperidol has been shown to result in increased AADC activity (Hadjiconstantinou & 
Neff, 2008; Zhu, Juorio, Paterson, & Boulton, 1993). Furthermore, okadaic acid, a 
protein phosphatase I (PP1) inhibitor, also results in increased AADC activity 
(Hadjiconstantinou & Neff, 2008). This suggests that antagonism of the D1-like 
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excitatory receptors leads to decreased inactivation of PP1, and as a result, greater 
dephosphorylation and inactivation of AADC.  In this way, AADC is also regulated by 
dopaminergic feedback.
In addition to enzymes which regulate dopamine synthesis and further 
metabolism, dopamine's concentration is also regulated, specifically in the synapse, by 
transport proteins in the cell membrane of the presynaptic axon. The vesicular 
monoamine transporter 2 (VMAT2) is an integral membrane protein that, as the name 
suggests, facilitates transport of monoamines into vesicles. According to a literature 
review by Kvetňanský, Lu, and Ziegler (2013), only VMAT2, not VMAT1, is expressed 
in neurons, and VMAT2 has a tendency to colocalize with TH.  It has been previously 
demonstrated that expression of VMAT2 is downregulated in response to chronic stress in
the nucleus accumbens (Zucker, Weizman, & Rehavi, 2005), and since vesicular transport
is necessary for neurotransmitter release, this further contributes to decreased 
extraneuronal dopamine levels. There is also general agreement about the effects of 
chronic stress on expression of Dat1. In various neural structures including the nucleus 
accumbens (Scheggi et al., 2002), caudate nucleus, and putamen (Isovich, Mijnster, 
Flügge, & Fuchs, 2000), increases seen in extraneuronal dopamine levels are generally 
attributed to decreased expression of DAT on the presynaptic neuron. Once dopamine is 
removed from the synapse, it is broken down by a number of catecholamine degradation 
enzymes, including monoamine oxidase (MAO).  Kvetňanský et al. (1984) demonstrated 
that MAO activity is decreased in the hypothalami of animals subjected to repeated 
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Figure 3: The catecholaminergic synthesis pathway. TH: tyrosine hydroxylase; TD: tyrosine decarboxylase;
AADC: aromatic L-amino-acid decarboxylase; CYP2D6: cytochrome P450 2D6; DBH: dopamine β-
hydroxylase; PNMT: phenylethanolamine N-methyltransferase.
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stress, which downregulates the process of catecholamine degradation.
To summarize, there are five subtypes of dopamine receptor, which are 
differentially expressed across various regions of the brain. The D1-like excitatory 
receptors stimulate the cAMP pathway and upregulate transcription of CREB target 
genes, while the D2-like inhibitory receptors inhibit cAMP. The abundance of dopamine 
itself  is regulated by a number of enzymes—those upstream which facilitate conversion 
of tyrosine to dopamine, and those downstream which convert dopamine into 
norepinephrine and epinephrine. Synaptic concentration of dopamine is regulated by 
transporters which facilitate the reuptake of excess dopamine into the presynaptic neuron,
as well as enzymes which degrade the dopamine once it has been reabsorbed. As this 
network of genes demonstrates, dopaminergic signaling is highly regulated.
NURR1
NURR1 (also known as NR4A2) is a member of the nuclear receptor family of 
proteins which has been implicated in transcription of genes necessary for dopaminergic 
regulation. Nuclear receptors are a class of proteins which bind to hormone response 
elements (HREs) in promoter regions of DNA to activate transcription of genes coupled 
to the specific receptor's RE. Once bound, these receptors initiate transcription through 
the recruitment of additional complex substituents, such as coactivators and/or additional 
transcription factors (Wärnmark, Treuter, Wright, & Gustafsson, 2003). Khorasanizadeh 
and Rastinejad (2001) characterized these proteins as sharing a structure consisting of 
several features: a degenerate amino terminus, hinge region, and conserved DNA-binding
(DBD) and receptor-specific ligand binding (LBD) domains. However, structural studies 
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have indicated the lack of a ligand-binding pocket within the native conformation of 
NURR1, leading to its classification as an orphan receptor (Wang et al., 2003), as 
illustrated in Fig. 4.
NURR1 is first expressed in the midbrain at day 10.5 of embryogenesis, but its 
presence continues into maturation and adulthood (Torii, Kawarai, Nakamura, & 
Kawakami, 1999; Sakurada, Ohshima-Sakurada, Palmer, and Gage, 1999). It is believed 
to be transcriptionally activated by the NF-κB and the cyclic AMP response element 
binding protein (CREB) factors, based on binding assays involving the Nurr1 promoter 
region (McEvoy et al., 2002; Kovalovsky et al., 2002), and according to Liu, Serova, 
Kvetňanský, and Sabban (2008), immobilization stress has been demonstrated to induce 
transcription of Nurr1 in the adrenal medulla. There are multiple 5'-ATTTA-3' sequences 
in the 3' untranslated region of the gene, a sequence which is known to cause mRNA 
instability and is suggestive of an immediate early gene, or IEG (Torii et al., 1999).
NURR1 is a member of the Nur77 receptor family, alongside Nur77 and NOR-1, 
the three show a large amount of sequence homology, sharing the NBRE consensus 
sequence consisting of the sequence 5'-AAAGGTCA-3' (Sacchetti, Mitchell, Granneman,
& Bannon, 2001; T. Kim et al., 2013). Although an orphan receptor, there have been 
cases where RXR has been demonstrated to dimerize with NURR1 in a mechanism 
which is believed to promote increased expression of target genes (T. Kim et al., 2013), 
and at least one study has demonstrated dysfunctional dopamine signaling and 
locomotion in an RXR knockout mouse model (Krȩzel et al., 1998). However, RXR is 
not necessary for expression of all NURR1 targets (Sacchetti et al., 2001).
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Figure 4: Crystal structure of NURR1 (Helix 1, DNA binding domain not pictured). Notice that the 
traditional position of the ligand binding domain (between helices 3 and 4, in yellow) is blocked due to 
close proximity of hydrophobic residues. Image generated from PBD 1OVL, residues 363-598, using 
DeepView/SPDBV (v. 4.1.0, Swiss Institute of Bioinformatics, Lausanne, Switzerland.)
There is a lack of differentiation of dopaminergic neurons in Nurr1-null mice 
(Kadkhodaei et al., 2009), and overexpression of the gene induces mesenchymal stem 
cell differentiation into dopaminergic neurons (Park et al., 2012), suggesting a major role 
for the gene in neuronal development. However, it is also implicated as a major 
regulatory component of mature dopaminergic neurons, as it has been demonstrated to act
as a transcriptional activator of proteins crucial for dopaminergic signaling, such as 
tyrosine hydroxylase (Sakurada et al. 1999; T. Kim et al., 2013) and the dopamine 
transporter (Sacchetti et al., 2001; Bannon et al., 2002). Because of this role, NURR1 has
garnered interest as a target for therapeutic interventions aimed at dopamine-related 
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psychiatric disorders. Polymorphisms and mutations of the gene have been linked to 
Parkinson's disease (Carmine et al., 2003), bipolar disorder, and schizophrenia 
(Buervenich et al., 2000), and tissue analyses have found downregulation of NURR1 in 
both peripheral neurocytes and dopaminergic neurons of PD patients (Kadkhodaei et al., 
2009). Furthermore, it has been demonstrated that a deficiency in NURR1 leads to a 
decrease in dopamine levels, which may be the mechanism by which it leads to 
Parkinson's  (Park et al., 2012). A Nurr1-heterozygous mouse model showed 
hyperactivity which was reduced by administration of haloperidol, a DRD2 antagonist, as
well as an increase in immobility during the Forced Swim Test (indicating depression), 
consistent with symptoms of schizophrenia (Rojas, Joodmardi, Hong, Perlmann, & 
Ögren, 2007).
Dopamine Transporter (Dat1)
The dopamine transporter (also known as SLC6A3) is a protein found in the 
synaptic membrane that facilitates the reuptake of synaptic dopamine into presynaptic 
terminals (Sacchetti et al., 2001; Felten, Montag, Markett, Walter, & Reuter, 2011). It has
been demonstrated that Dat1 is induced by NURR1 independently, without the necessity 
of RXR binding. Furthermore, it has been demonstrated that binding to the NBRE is not 
necessary for NURR1 activation of Dat1 transcription, a phenomenon which has not been
otherwise observed in the Nur77 family; but which has been demonstrated in the 
interactions of other nuclear receptors (Sacchetti et al., 2001).
There is a variable number of tandem repeats (VNTR) sequence present in the 
Dat1 gene, and this polymorphism alters transporter density, resulting in a downstream 
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effect on synaptic dopamine concentration (Felten et al., 2011). However, the 
polymorphism showed no significant effect on results of the Affective Neuroscience 
Personality Scales (Felten et al., 2011), the Schedule for Affective Disorders and 
Schizophrenia-Lifetime Version, and the Structured Clinical Interview for DSM-IV—
Patient Version (Frisch et al., 1999). Furthermore, meta-analyses of existing literature 
showed that the polymorphism showed no association with schizophrenia (Gamma, 
Faraone, Glatt, Yeh, & Tsuang, 2005; Joober et al., 2000). Nevertheless, it is believed that
DAT pathology may play a role in the same disorders as NURR1, along with disorders 
involving attention deficits and addiction (Joober et al., 2000). Rowe et al. (1998) 
presented data to suggest that this VNTR polymorphism may play a role in the pathology 
of “internalizing disorders:” generalized anxiety, social anxiety, phobias, obsessive-
compulsive disorder, and Tourette's syndrome.
Tyrosine Hydroxylase (TH)
As mentioned previously, tyrosine hydroxylase is the rate-limiting enzyme in 
catecholamine synthesis (Thibaut et al., 1997), which converts the amino acid tyrosine 
into L-DOPA. In rodents, it has been demonstrated that TH is necessary for dopaminergic
functioning; however, in humans, while it has been confirmed that the NBRE is present 
in the Th promoter region (Jin et al., 2006), it is not strictly necessary, as the CYP2D6 
pathway presents an alternative method of dopamine synthesis, and it has been 
demonstrated that siRNA downregulation of human NURR1 transfected into an animal 
model did not affect TH expression (Jin et al., 2006). Further investigation showed that 
the sequence homology between human and murine Th promoter regions is only 46.4% 
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(Jin et al., 2006). Despite its biological redundancy in humans, it is included in this study 
because of its known significance in rodent models.
Despite this redundancy, however, mutations in the human Th gene can still 
produce a phenotype consistent with certain psychiatric disorders. A perfect ten 
tetranucleotide repeat located in the first intron of the gene shows a significant correlation
with schizophrenia, whereas a 1 base-pair deletion within this sequence is considered 
wild-type (Thibaut et al., 1997). A postmortem analysis of depressive patients and suicide
victims demonstrated an upregulation in TH transcription in the locus coeruleus, a region 
of the brainstem, which the authors believed to be an adaptive mechanism based on low 
norepinephrine levels (Zhu et al., 1999). This suggests that conversely, a functional 
mutation in TH may also cause depressive symptoms, as without it, neurons which lack 
the necessary enzymes for the secondary dopamine synthesis pathway may present with 
low norepinephrine levels. Polymorphisms in CYP2D6 have been linked to tardive 
dyskinesia and other movement disorders in response to second-generation antipsychotic 
medications, suggesting that it plays an equally vital role in dopamine synthesis (Arranz, 
Blanco, & Samperiz, 2016). Additionally, another study of TH and symptomology found 
a significant link between certain allelic variations of the gene and occurrence of bipolar 
disorder (Serretti et al., 1998).
Despite the evidence that an otherwise healthy individual can overcome 
abnormally low TH levels by alternate dopamine synthesis pathways, if this abnormality 
is compounded with abnormalities in sister pathways, it can cause a number of 
psychiatric symptoms. Therefore, as with DAT, there is a possibility that low TH levels 
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can be responsible for NURR1-related symptoms in individuals with an irregularity in 
CYP2D6 or its synthesis.
Epinephrine and the β-Adrenergic Receptors
As mentioned previously, epinephrine/adrenaline is the final endpoint of the 
catecholaminergic synthesis pathway, and is the main neurotransmitter implicated in the 
physiological manifestations of the “fight-or-flight” response. The adrenergic receptors 
are grouped into two classes of G-protein coupled receptors by their effects on systemic 
circulation, α (vasoconstrictive) and β (vasodilating), and of the latter, there are three 
subtypes (Waarde, Vaalburg, Doze, Bosker, & Elsinga, 2004). All three β-receptors are 
coupled to the excitatory Gαs protein (Gurdal, Friedman, & Johnson, 1995; Sidhu, 1998), 
thereby leading to activation of the same adenyl cyclase pathway as the excitatory 
dopamine receptors and culminating in increased phosphorylation of CREB.
A study by Patki, Atrooz, Alkadhi, Solanki, & Salim (2015) showed increased 
hippocampal (as well as prefrontal cortical and amygdalar) epinephrine in response to a 
several-day social defeat paradigm. H. Kim et al. (2013) also demonstrated that a control 
group of animals exposed to chronic cold stress showed a significant upregulation in 
transcription of phenylethanolamine N-methyltransferase (PNMT), as well as a 
significant decrease in dopamine and a significant increase in adrenaline levels in the 
hypothalamus and hippocampus.
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II. HYPOTHESIS AND AIMS
Based on what has been previously discovered about the roles dopamine plays in 
learning, memory, and emotion, we hypothesize that transcription of genes which encode 
proteins that contribute to the synthesis and signal transduction of dopamine is higher in 
the hippocampi of animals which display higher levels of spatial and emotional memory. 
In particular, we focused on the following areas and aims:
 Aim 1: To assess the relationship between dopamine receptor gene expression and
behavioral performance following chronic stress exposure in mice.  
 Aim 2: To test whether expression of genes that facilitate dopaminergic signaling 
in the hippocampus (Nurr 1 and Th) is positively associated with behavioral 
performance.
 Aim 3: To test whether expression of a gene that inhibits dopaminergic signaling 
in the hippocampus (Dat1) is negatively associated with behavioral performance.
In regards to Aim 1, although the D1-like excitatory and D2-like inhibitory dopamine 
receptors serve opposite roles in transmission of the dopaminergic signal, we anticipate 
an overall increase in mRNA expression across all subtypes in higher-performing animals
(in line with Aim 2), rather than a bidirectional change dependent on receptor subtype. In 
Aim 2, Nurr1 is a nuclear receptor which facilitates transcription of dopamine-regulation 
genes, and Th is necessary for the synthesis of dopamine from tyrosine. In Aim 3, Dat1 is
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 responsible for facilitating reuptake of dopamine into the presynaptic neuron, thereby 
preventing postsynaptic binding. By analyzing a variety of genes involved in different 
aspects of this system, the goal of the current study is to determine which aspect may be 
responsible for memory deficits resulting from dopamine dysregulation.
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III. MATERIALS AND METHODS
Ethics Statement 
All procedures involving live animals were performed consistent with the 
standards set forth by the National Institutes of Health and the National Research 
Council's Guide for the Care and Use of Laboratory Animals. Studies were approved by 
the Wright-Patterson Air Force Base Institutional Animal Care and Use Committee.
Responsibilities of the Author
Although the author of the current study performed the subsequently mentioned 
animal handling procedures as part of her laboratory responsibilities, all animal handling 
in the current study was performed prior to her membership in the lab, as described in 
Carhuatanta, Shea, Herman, and Jankord (2014). RNA sequencing analysis was 
performed by Dr. Seung Ho Jung. The author of the current study designed the hypothesis
and research aims, and was provided the expression data derived from RNA sequencing, 
as well as raw behavioral data, and performed the statistical analysis.
Animals
9 week old male BXD (C57BL/6J and DBA/2J recombinant inbred strain, 
Jackson Laboratory, Bar Harbor, ME, USA) mice were housed individually and given 
standard food and water ad libitum. Prior to the experimental paradigm, animals were 
allowed to acclimate to the animal facility for a period of ten days. The facilities were 
climate controlled under the following parameters: 18-24°C, 30-70% humidity, 12 hour 
19
dark/light cycle. All experimental handling occurred Monday through Friday of each 
week, during the light cycle.
Chronic Variable Stress
All animals were subjected to a four-week Chronic Variable Stress regimen, 
during which subjects were exposed to up to two of the following stressors each day (5 
days per week): 15 minutes of cold (4°C) exposure, 30 minutes of hypoxia, 1 hour of 
cage placement on a shaker, novel housing overnight, and 30 minutes of open field 
exposure. The sequence of stressors was randomized to prevent habituation; however, all 
animals were subjected to an identical sequence. The handling schedule is summarized in
Table 1.
Table 1: Summary of stressors and behavioral assays over the experimental period.
Elevated Plus Maze
The Elevated Plus Maze is a behavioral assay which serves to quantify an animal's
anxiety level (Hogg, 1996). The maze was elevated 1 meter from the floor and consisted 
of two pairs of 40 cm x 8 cm platforms arranged in a cross: one in which the arms are 
open to the air, the other enclosed with 29.5 cm tall walls constructed of gray plexiglass. 
The natural inclination of rodents is for dark, enclosed spaces, and therefore, lack of 
anxiety is measured by the percent of the total test time (5 minutes) which is spent 
exploring the open arms. Video of each trial was recorded and duration spent in each arm 
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was automatically calculated using EthoVision XT 7.0.418 tracking software (Noldus 
Information Technology, Leesburg, VT, USA).
Morris Water Maze
The Morris Water Maze is a behavioral assay used to examine subjects' spatial 
memory and learning abilities (Morris, 1984). Briefly, subjects are placed into a pool of 
opaque water, under the surface of which is a solid platform which when stood upon, 
enables the majority of the animal's body to remain above water. During a single day, 
subjects are placed into the pool in varying quadrant positions, and are provided with 
environmental directional cues (large varying printed symbols positioned above the pool).
Various measures of each trial (4 per animal per day) are recorded, including subject 
position, swim path, speed, and latency to platform. Subjects completed four trials per 
day, for five days, followed by a one day learning extinction procedure during which the 
platform was removed from the pool, and on the final day, post-extinction recall was 
tested. The final two days of the study were performed for parallel studies; the current 
study examined average latency to platform over 20 trials (4 trials per day across the first 
five days). All trials were recorded using EthoVision XT.
Fear Conditioning
Fear conditioning, as the name suggests, is utilized as an assessment of emotional 
learning and memory (Phillips & LeDoux, 1992). Subjects were placed into sound 
dampening chambers which contained cameras and consisted of two metal (side) and two
plexiglass (front and back) walls (Med Associates, Inc., St. Albans, VT, USA). The first 
day of the three-day assay consisted of four 3 kHz tones at 85 dB, lasting 30 seconds 
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each, which were immediately followed by a 2 second, 0.75 mA shock delivered through 
the floor of the chamber. Between each tone/shock pairing, there was a thirty second 
interval. Day 1 served to establish classical conditioning, pairing the unconditioned 
freezing response to fear with the pre-shock tone. On day 2, subjects were placed into the 
conditioning chamber once more, in the absence of both tone and shock, and freezing 
behavior (both instances and percent time frozen) were observed. On day 3, the metal 
grid on the floor of the chamber was replaced with white plexiglass, and freezing 
behavior was observed in response to a tone in the absence of a shock. Instances of 
freezing and time frozen on day 3 were analyzed as a measure of emotional memory.
Tissue Collection and RNA Sequencing
The day following the conclusion of all behavioral assays, subjects were 
euthanized via rapid decapitation, and brain tissue was quickly removed and stored at 
-80C. Whole hippocampi were dissected from each sample, and total RNA was isolated 
via an RNeasy Mini Kit (Qiagen, Valencia, CA, USA) according to the provided 
directions. Isolated RNA samples were shipped overnight to the Next Generation 
Sequencing facility at UCLA. Whole transcriptome RNA sequencing was performed 
using an HiSeq 2500 instrument (Illumina, San Diego, CA, USA), and multiplexed files 
were downloaded from the UCLA database, demultiplexed, and merged into one file.
Bioinformatics
The FASTX-Toolkit (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 
USA) was utilized to remove sequencing adapters (FASTQ Clipper) and remove barcodes
and noise (FASTQ trimmer). Quality control of files was validated using FastQC 
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(Babraham Institute, Cambridge, Cambridgeshire, UK). TopHat (v. 2.0.6, Johns Hopkins 
University, Baltimore, MD, USA) and Bowtie (v. 0.12.8, Johns Hopkins University) were
used to align reads to the Mus musculus (NCBIM37) genome assembly hosted by the 
University of California, Santa Cruz Genome Browser. Once aligned, HTSeq (v. 0.5.3p9, 
European Molecular Biology Laboratory, Heidelberg, Germany) was used to quantify 
reads, and DESeq (European Molecular Biology Laboratory) was utilized to normalize 
the quantifications and discard genes which were not displayed across all samples. Read 
values were normalized by dividing the raw read count by a scaling factor which 
accounted for the assumption that the majority of genes analyzed were not differentially 
expressed. All bioinformatic analysis was performed by Dr. Seung Ho Jung.
Analysis
Normalized read levels for genes of interest from each subject were extracted 
from processed data. Statistical analysis and generation of graphical data representations 
were performed using SigmaPlot (v. 13.0, Systat Software, San Jose, CA, USA). Subjects
were sorted and grouped by both mRNA expression and individual task performance, and
due to the previously mentioned predictions of directional change, the highest and lowest 
quadrants were compared via one-tailed t-tests. Correlations across the entire population 
were measured by the Pearson product-moment correlation coefficient (“Pearson's r”). 
Quantitative Trait Loci (QTL) mapping was performed using GeneNetwork (University 
of Tennessee, Knoxville, TN, USA), with 1000 permutation tests and 2000 bootstrap 
tests.
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IV. RESULTS 
RNA sequencing
The hippocampi of all 25 subjects underwent whole-transcriptome RNA 
sequencing. All of the genes studied displayed a range of relative expression values, as 
seen in Table 2. The results are visually summarized as well in Fig. 5.
Categorization of groups by mRNA expression
Subjects were grouped into quartiles (n=6, with the exception of Drd3, which had 
10 subjects displaying a transcription level of zero) according to mRNA expression level. 
Task performances were compared between the highest and lowest quartiles, and p-value 
was determined by one-tailed t-test (Figs. 6-8; Table 3). The resulting data shows a 
statistically significant difference in latency to platform during the Morris Water Maze 
(spatial memory), as well as instances of and time spent displaying freezing behavior 
during fear conditioning (emotional memory), between high and low Nurr1 mRNA 
expression groups (Fig. 6; MWM p = 0.0351; FC p = 0.009).
Categorization of groups by task performance
Subjects were grouped into quartiles according to individual task performance. 
mRNA expression levels were compared between the highest and lowest quartiles, and p-
value was determined by one-tailed t-test  (Figs. 9-12; Table 4). While we see a similar 
trend of higher performance (lower latency to platform in MWM, higher time in open 
arms in EPM, and both lower freezing instances and total time frozen in FC) associated
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with higher gene expression, no statistically significant difference was observed. 
Likewise, no statistically significant change was observed for any task or any other gene 
studied.
Nurr1 correlations across entire population
Given that initial analysis demonstrated a significant change in task performances 
across Nurr1 expression groups, the correlations between performance and expression 
variables were examined across the entire subject population. While not meeting the 
threshold for statistical significance, weak negative correlations (as measured by 
Pearson's r) were demonstrated for both latency to platform (MWM) and percent time 
frozen (FC), as shown in Figs. 13 and 14. A Pearson's r value between |0.3| and |0.5| 
indicates a weak correlation between variables, whereas a value less than |0.3| indicates a 
negligible correlation, while a positive value represents a positive correlation and 
negative values represent negative correlations. Given that the Pearson's r values for 
MWM latency to platform and FC total time frozen are solidly in the “weak” range, while
not statistically significant, these results are encouraging, and warrant further 
investigation.
Quantitative Trait Loci mapping
Quantitative traits are polygenic; in other words, there are multiple genes, or 
regions of genes, which influence the phenotype. To explain simply, a series of 
associations between genomic regions and phenotype are aggregated to determine which 
regions are associated with the trait of interest. In the current study, the goal of QTL 
mapping was to determine what areas of the genome were predictive of hippocampal 
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Nurr1 mRNA expression. At each region of the subjects' chromosomes, the variant 
corresponded randomly to either the C57 or DBA strains due to the randomness of 
genetic recombination, and the higher the peak for a given region of the genome, the 
higher association there was between a subject's variant at that position and their 
normalized transcription of Nurr1. While no peaks were observed above the likelihood 
ratio statistic (LRS) significance threshold of 18.21, chromosomes 4, 6, and 11 
demonstrated peaks above 11.37, the suggestive threshold (Fig. 15). Closer analysis 
identified 20 loci across these three chromosomes which may contribute to variation in 
expression (Table 5). The chromosomal regions which demonstrate peaks associated with
Nurr1 expression, especially on chromosome 11, while not definitively demonstrated to 
be the cause of the demonstrated behavioral trends, are nevertheless predictive of 
performance on memory-related tasks. By narrowing down the predictive regions, this 
paves the way for identification of causative genes and more thorough pathway mapping.
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Table 2: Expression of target gene mRNA expression across the entire studied population
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Figure 5: Graphical representation of target gene mRNA expression. Dotted lines represent the divisions between Quartiles 1 and 2, and Quartiles 3 and 4, used for
analytical grouping by expression level Range of Quartile 1 for Drd3 was extended due to identical values of a quantity greater than the standard n=6.
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Figure 6: Comparison of task performance between high and low  Nurr1 mRNA expression groups. P-
values determined by one-tailed t-test,  n=6 for both groups. Notice that Morris Water Maze latency to
platform, and time frozen during fear conditioning demonstrated statistical significance between expression
groups. Error bars denote standard error. * denotes statistical significance (p < 0.05).
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Figure 7:  Comparison of  task performances between  Nurr1 target  gene mRNA expression groups.  No
statistically significant differences were observed between any expression group pairs. Error bars denote
standard error.
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Figure  8:  Comparison of  task  performance between dopamine receptor  mRNA expression  groups.  No
statistically significant differences were observed between any expression group pairs. Error bars denote
standard error
Table 3: P-values of one-tailed t-tests for subjects grouped by mRNA expression. MWM, average latency to
platform in Morris Water Maze; EPM, percent time spent in open arms in Elevated Plus Maze; FC Count,
instances of freezing during day three of fear conditioning; FC Percent, percent of total time spent frozen
during fear conditioning. * denotes a p-value less than 0.05.
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Figure 9: Comparison of Nurr1 mRNA expression levels between high and low task performances. No 
statistically significant changes were observed between groups for any of the behavioral assays performed. 
Error bars denote standard error.
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Figure 10: Comparison of  Dat1 mRNA expression levels between high and low task performances. No
statistically significant  differences were  observed  between groups for  any behavioral  assay performed.
Error bars denote standard error.
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Figure  11:  Comparison  of  Th  mRNA expression levels  between high  and  low task performances.  No
statistically significant differences were observed between any performance group pairs. Error bars denote
standard error.
34
Figure  12:  Comparison  of  dopamine  receptor  mRNA expression  levels  between  high  and  low  task
performances. No statistically significant differences were observed between any performance group pairs.
Error bars denote standard error.
 
Table 4: P-values of one-tailed t-tests for subjects grouped by task performance. MWM, average latency to
platform in Morris Water Maze; EPM, percent time spent in open arms in Elevated Plus Maze; FC Count,
instances of freezing during day three of fear conditioning; FC Percent, percent of total time spent frozen
during fear conditioning.
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Figure 13: Correlation of Nurr1 mRNA expression and latency to platform during Morris Water Maze 
across the entire subject population. The Pearson's r value denotes a weak correlation, although the p-value 
falls outside the range of statistical significance.
Figure 14: Correlation of Nurr1 mRNA expression and time spent frozen during day three of fear 
conditioning. The Pearson's r value denotes a weak correlation, although the p-value falls outside the range 
of statistical significance.
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Figure  15:  Quantitative  Trait  Loci  mapping  of  Nurr1 mRNA expression.  Notice  that  regions  within
chromosomes 4, 6, and 11 fall above the grey line (the LRS threshold for suggestibility).
Table 5:  Suggestive loci  associated with  Nurr1 mRNA expression (as  derived from the QTL mapping
illustrated in Fig. 15).
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V. DISCUSSION
This study examined the transcription of several genes related to the regulation of 
dopaminergic signaling. Our results demonstrate that in tests of spatial and emotional 
memory, there is a positive relationship between transcript abundance of a regulatory 
element of dopaminergic signaling, Nurr1, and task performance (Figs. 6, 13, 14); 
however, no other studied genes demonstrated such a relationship. Furthermore, they 
demonstrate that these genes show a range of variation across our subject population, and
that in regards to Nurr1, there are multiple chromosomal regions which may affect 
mRNA expression by allelic variation. However, this study also raises the question of 
whether NURR1 affects memory by dopaminergic regulation, or some other mechanism. 
Nurr1
Given that both statistically significant changes between expression groups and
weak correlations between transcription and task performance were observed,  the present
study agrees with previous literature that suggest a major role of  Nurr1 in the studied
behaviors.  Colón-Cesario  et  al. (2006)  found  that  rats  treated  with  antisense  DNA
corresponding to  Nurr1 successfully knocked down protein  expression and interfered
with discrimination of relevance of spatial information during a spatial memory task. In
other words,  knockdown of Nurr1 impairs spatial long term memory, thus demonstrating
that it plays a vital role . Furthermore, Hawk et al. (2012) refer to several previous studies
that provide evidence of a role for Nurr1 in emotional and spatial memory. One such
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 study  demonstrated  an  increase  in  Nurr1 in  the  CA1  and  CA3  regions  of  the
hippocampus  following hippocampal  learning.  Another  demonstrated  that  in  a
heterozygous  Nurr1 null  model,  mice  show  impaired  emotional  memory  (measured
through a passive avoidance task). The current and previous studies both demonstrate a
role  for  NURR1  in  hippocampal  memory  formation;  specifically,  in  relevance
discrimination during memory consolidation.
One detail of special interest is that while a significant change in task performance
was observed between groups when subjects were grouped by Nurr1 expression, the 
significance did not hold true when subjects were grouped by task performance. This is 
likely due to the fact that Nurr1 influences task performance, but is not the only factor to 
do so. The observation that mRNA expression can weakly predict task performance, but 
task performance does not predict Nurr1 mRNA expression, suggests a relationship 
confounded by the contributions of other signaling cascades. Furthermore, in two of the 
behavioral measures (latency to platform in the Morris Water Maze and percent time 
frozen in Fear Conditioning), a weak correlation was demonstrated between Nurr1 
expression and task performance; however, the p-values exceeded the threshold of 
significance (p < 0.05).
Nurr1 targets and dopamine receptors
Despite our initial model which predicted a significant relationship between task 
performance and expression of the direct targets of NURR1 which were examined in the 
present study, no significant group differences or correlations were observed. As 
previously mentioned, vital pathways such as catecholamine synthesis demonstrate the 
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existence of alternate mechanisms, and furthermore, many genes contain multiple 
response elements within their promoter regions. In addition to NURR1, both the human 
and mouse Th promoters contain binding elements for HNF-3β, HOXA4, and HOXA5 
(Kessler, Yang, Gollomp, Jin, & Iacovitti, 2003). The Dat1 promoter region likewise 
contains response elements for CREB and AP-1, along with several potential response 
elements which were identified (but not experimentally verified) by Bannon et al. (2001).
While a change was expected, due to the fact that previous literature has demonstrated 
that mutations or knockdowns of Nurr1 are associated with dopaminergic dysfunction, 
transcription of these genes is regulated by multiple pathways. Therefore, this provides a 
credible explanation for the lack of a relationship between Nurr1 expression-related task 
performance, and expression of NURR1 target genes.
Like the target genes of NURR1, no significant correlation was observed between 
task performances and expression of dopamine receptors. While a relationship was 
predicted based upon evidence suggesting that synaptic dopamine concentration regulates
receptor expression, this is consistent with the lack of correlation in Th and Dat1, as both 
these genes play a role in regulation of dopamine's presence in the synapse. Interestingly, 
while not statistically significant, there are complimentary trends in the Elevated Plus 
Maze and fear conditioning time frozen data for the dopamine receptors. Low Drd1 and 
Drd2 expression, as well as high Drd5 expression, are associated with higher time in 
EPM open arms, indicative of a lower unconditioned anxiety response, and lower time 
frozen during FC, indicative of a less solid conditioned reaction to an unpleasant 
stimulus. However, low Drd3 and high Drd4 demonstrate a trend toward higher time in 
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open arms, but lower time spent frozen during fear conditioning. While the similarity in 
trends between Drd1 and Drd5, as well as Drd3 and Drd4 are to be expected as they are 
grouped together by G-protein response, it is worth noting that Drd2, in this instance, 
demonstrates a trend consistent with the D1-like receptors.
Interestingly, our observed relative dopamine receptor mRNA levels conflict with 
previous literature. Meador-Woodruff et al. (1994) estimated that hippocampal Drd2, 
Drd4, and Drd5 levels were roughly equal, while Drd3 expression was 2- to 5-fold lower,
and Drd1 mRNA levels were 2- to 3-fold lower still. Likewise, Khan et al. (1998) stated 
that Drd4 mRNA is the most prevalent inhibitory dopamine receptor type in the 
hippocampus. An examination of mean mRNA level across the entire population for each 
dopamine receptor subtype in the current study, however, demonstrated that this was not 
the case. Our results indicated that Drd2 was the most abundant, followed closely by 
Drd1. Drd5 was approximately -1.5-fold lower than Drd1, and by comparison to the other
subtypes, the levels of both Drd3 and Drd4 were negligible (Fig. 16). Although the 
current study provides no non-stressed control for comparison, these studies may suggest 
that chronic stress changes the relative ratios of hippocampal dopamine receptors.  
Animals were restrained for one hour on the morning of the final day, prior to the 
collection of tissues following euthanasia. Based on previous studies, such as that 
described by Jankord and Herman (2008), we believe that exposure to this novel stressor 
led to changes in the mRNA expression profile. Thus, the mRNA expression profiles 
described in this study represent an interaction between the previous chronic stress and 
this final acute stressor, which immediately preceded tissue collection. Because tissue 
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samples were collected approximately one hour after the final stressor, changes in in 
immediate early genes (IEGs), like Nurr1, were likely due, at least in part, to the acute 
stress response. While this timeframe likely captured changes in IEGs, we would not 
necessarily expect to see changes in downstream genes, such as Th and Dat1, which 
require additional time for transcriptional changes to filter down the signaling cascades.
Figure 16: The observed ratios of hippocampal dopamine receptor mRNA levels are not in agreement with 
previous literature which suggests Drd4 is the most abundant subtype mRNA. Error bars denote standard 
error.
Final Thoughts
This study demonstrates that hippocampal expression of Nurr1 predicts 
behavioral performance in mice. Our results show that  Nurr1 mRNA transcription levels 
predict performance during tests of spatial and emotional  memory. We did not observe a 
statistically significant relationship between other dopaminergic genes measured (Dat1, 
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TH, and five subtypes of dopamine receptor) and behavioral performance.  Overall, this 
study is consistent with previous literature that suggests a role for NURR1 in memory, 
and provides evidence for genetic variability in its regulation. However, it also provides 
preliminary evidence that NURR1 may also modulate memory-related abilities by some 
mechanism other than regulation of Dat1 and TH transcription, which may be 
independent of dopaminergic regulation entirely.  
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